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Neuro-oncology covers diagnostic and therapeutic management of primary and
secondary tumors of the nervous system, non-metastatic neurological
complications of cancer and genetic diseases.
Those entities, particularly heterogeneous, interface (varying degrees) with
rehabilitation (physical, cognitive or language aspects).
The majority of primary tumors are glioblastomas (WHO grade IV).
Therapeutic progress has been made in recent years. Treatment consists of
surgery, radiotherapy and chemotherapy including temozolomide. Targeted
therapies, mainly focused on angiogenesis, are just add to the usual arsenal.
Unfortunately, in most cases, the prognosis is too quickly involved and the
management of physical medicine and rehabilitation (PMR), absolutely
essential, aim to help patients to maintain their autonomy (full or partial) as long
as possible, and get at home, despite many deficits, at least with a relative
comfort.
Anaplastic gliomas (WHO grade III) represent an heterogeneous entity being
dismembered on clinical, radiological, morphological and molecular clinical
aspects. The evolution is sometimes very short in few months (rapid
transformation to a glioblastoma phenotype) or sometimes longer over 15
years (it looks like to a diffuse low-grade glioma). Rehabilitation should be
discussed on a ‘‘case by case’’ basis between neurological/oncological teams
and those from rehabilitation.
Diffuse low-grade gliomas (WHO grade II) mainly affect young people
(midlife). The most important advances in recent years concern surgery. The
slowness of the evolution allows brain plasticity. It opens the door to functional
surgery most often awake. In specialized teams, operative morbidity (excluding
expected and transient worsening observed in the weeks following the
procedure) is less than 5% (or less than 1%). Chemotherapy (usually oral and
outpatient) is available either in the case of inoperable tumors or after surgery
when growth is considered as significant (if a reoperation can not be performed).
The timing of radiotherapy is discussed. Its potential neurotoxicity and the fact
that its impact is the same regardless of the time of realization make that, in a
majority of teams, this treatment is delayed. Rehabilitation, most often
intensive, is proposed just after surgery in order to supervise and optimize
recovery. The aim is clearly to allow patients to lead a normal socio-professional
life. It is also for this entity that a randomized trial (rare in this area)
demonstrated the interest of cognitive rehabilitation. It is not impossible that, in
a near future, rehabilitation can be initiated in the preoperative period with the
aim to possibly amplify the mechanisms of plasticity and thus to promote a
surgical procedure whose quality is directly related to survival.
Other primary tumors, excluding meningiomas, are rare. Progression profiles
appear very heterogeneous across entities and each nosology (pilocytic
astrocytomas, lymphomas, medulloblastomas, germ cell tumors, nerve sheath
tumors. . .). If rehabilitation should be considered, the basis should be discussed
by all involved actors.
Cerebral and meningeal metastases are becoming increasingly important in
daily neuro-oncology. It concerns one quarter to one third of patients treated for
cancer. Although the event remains pejorative specific therapeutic are in
development: optimization of surgery, stereotactic radiotherapy, chemotherapy
or new targeted therapies and allow, for a little more than 10% of the affected
population, to obtain long survival. Again, any specific rehabilitation should be
offered at the individual level and thus discussed with all the teams.
Finally, neuro-oncology/PMR interfaces also cover the management of
neurological complications of cancer treatments, as peripheral (toxic
polyneuropathy. . .) and central (immunological or related to radiotherapy
side effects) or genetic diseases with their features (scoliosis, cerebrovascular
diseases, gliomas, cognitive deficits in neurofibromatosis, or ocular, brain or
spine hemangioblastomas for the Von Hippel Lindau disease. . .) all specific.
Transdisciplinary strategies will again, be essential.
In conclusion, the interfaces between neurooncological diseases and specialties
around the PMR are numerous. To date, only a minority of patients may benefit
from specialized care. The lack of facilities and staff could at least partially be
offset by strengthening the dialogue between specialists and the development of
joint works including collaborations such as those implemented between
SOFMER, AFSOS and ANOCEF (via the ‘‘supportive care, quality of life and
cognition’’ group). It is clearly a priority for us.
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Introduction.– Compared to manual drainage (DM), sequential pneumatic
compression is sometimes presented as less efficient. This is one of the major
consequences of the use of inadequate pumps or programs to irreversible
lymphoedema. Their substantive processing requires a retrograde program
starting at the top of the oedema.
Objective.– The response to a DM is compared to the one of a retrograde
pneumatic drainage (RPD).
Subjects and methods.– Today, the sample includes nine women (71 years old)
with an old (14 years) and persistent upper limb lymphedema. The DPR choose
was the Lymphassist1; a program of Hydroven121 (FlowtronTM, England). Its
algorithm was widely copied for the DM. The choice of the value of the
Lymphassist1 pressure is reduced to 30 or40 mmHg. The pressure of40 mmHg
was chosen for this study. The wave moves without pressure gradient. Each
treatment lasts 16 min and is followed by a rest time of 15 min. The order of
execution is drawn at random. The relative reduction of the oedema was
objectified by mercury (JSITM, SU4) gauge plethysmograph; the gauge placed
at 20 cm above the elbow, where the passage has been the most common.
Results.– DM produced a gradual reduction of oedema. It reached 11.9 ml/
100mloed after the 16 minutes of massage. After the same amount of time, the
RPD response was: 0 ml/100mloed.
Discussion.– DM assured an unsurprisingly decongestion and comparable to
our previous studies. In contrast, the Lymphassist1 showed complete
inefficiency at least into the phase of substantive treatment of a former
persistent lymphoedema of the upper limb.
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Purpose.– The world health organization advices the use of the international
classification of functioning disability and health as a basis for common
language and concepts for the health professionals. The objective of this study
was to evaluate the disability and health status after treatment for breast cancer
(i.e. body function and structure, activity, participation).
Patients and methods.– Patients receiving radiotherapy after breast cancer were
followed for one year. Functioning status were assessed before (T0), at the end
of the radiotherapy (T1), and after three (T3), six (T6) and twelve months (T12).
Body structure and function were assessed by means of: the pain threshold test,
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the isokinetic measurement of maximal torque for knee flexors and extensors,
the maximal power and the heart rate on ergometric bicycle and questionnaires
(Hospital Anxiety and Depression scale, Fatigue Severity Scale and Tampa
scale for kinesiophobia). Activity and participation were assessed by three
functional scales of the European Organization for Research and Treatment of
Cancer Quality of Life Questionnaire (EORTC QLQ-C30) [2]: Physical
functioning, Emotional status, Cognitive status, Social relationships, Capability
of assuming functions and roles. The proportion of patients returning to work
was also evaluated.
Results.– Eighteen patients completed all evaluations during one year. After the
end of the follow-up, patients had a poor muscle performance and a low
endurance on ergometric bicycle. They also had bilaterally a low pain threshold
for the upper limb. Patients were not significantly depressed but had high level
of fatigue and kinesiophobia. Social relationships and capability for function
and roles improved gradually over the one-year period. However, 25% of the
patients did not return to work.
Conclusion.– The patients treated for breast cancer present alterations of body
function and activities after one year and deserve rehabilitation and
arrangements both for work and everyday life, these findings being confirmed
by other authors [1,3].
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Introduction.– Rehabilitation and Neuro-oncology tend to develop joined
follow-up for patients with brain or medullar tumor. Recent guidelines in France
(still in progress) show evidence for such a trend [1]. Rehabilitation experience
in disability management and expertise in rehabilitation care pathways and
socio-medical follow-up can be useful for patients with neurological tumor
(whatever the evolution of the process) or for those with long-term neuro-
oncological sequellae in relation with their surgery or radio-chemiotherapy. We
report here our innovative experience of outpatient multidisciplinary services in
the Department of NeuroOncology. This activity was supported by the work
group of NeuroOncologie Soins de Support (NOSS) et the Association pour la
recherche sur les tumeurs cérébrales (ARTC).
Objectives.– The rehabilitation follow-up of outpatients takes place once a week
in the department of Neuro-oncology with a double assessment made by a
rehabilitation doctor and an occupational therapist. Patients are either addressed
by the neurologist or by the nurse coordinator. The majority of patients suffer
from a brain tumor (mainly glioblastoma). They either have incapacities
directly linked to their tumor or sometimes in relation with side effects of radio-
chemotherapy. Retrospective analyses of this rehabilitation follow-up show
interest for:
– motor disability with possible indication of toxin botulinum injection when
there is spasticity of the limb, fitting equipment (manual wheelchair, walking
and home daily living equipment), indications for a physical therapy
programme;
– cognitive and behavioral disability with communication aids, therapeutic
information on neuropsychlogical disorders for the patient and his caregiver
(heminegligence, dysexecutive disorders, apathy), indications for a speech
therapist programme;
– bladder and bowel disorders;
– home life project.
Discussion.– This rehabilitation follow-up points out the very importance of a
quick response of the various therapists and care partners. Rehabilitation
services should be easy and quick to access given the rapid evolution of many
patients. Major objectives lie in helping the patient-caregiver life home project
and maintaining a good quality of life. Preliminary assessments of this follow-
up highlight the usefulness of integrating rehabilitation expertise in the global
support programs for patients with tumor.
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Introduction.– Performing physical activity during a period of chemotherapy is
a promising support to improve fatigue and quality of life (QoL) [1,2]. It has
been shown efficient and feasible in various cancers. Pancreatic adenocarci-
noma (PAC) is the second digestive cancer in incidence and one of the poorest
prognostic tumors with 5-year survival rate < 5%. Effects of physical activity in
advanced PAC have not been explored. We aim to evaluate its potential role in
these patients.
Patients and methods.– Randomized multicentric phase III interventional study
to test the efficacy of an unsupervised home-based 16-week physical exercise
program. Specificities of PAC for physical activity program implementation
will be taken into account (physical activity partner instead of patients groups,
nutritional management). Main inclusion criteria: histologically confirmed,
unresectable PAC; scheduled for chemotherapy; WHO PS 0-2; age  18;
physical activity partner. Two study arms: intervention group with exercise
program (aerobic and resistance exercises) in addition to usual care; control
group with usual care. Primary objective: effects on fatigue (MFI-20) and QoL
(EORTC-QLQ-C30) at week 16, unified as co-primary endpoint. Secondary
objectives: effects on pain, depression, nutritional status, insulin resistance,
cancer-treatment tolerance, survival; adherence to the program, cost-effective-
ness analysis. Number of patients required: 220.
Results.– PAC patients are strongly affected by fatigue, thus they are expected to
benefit from a physical activity intervention. Moreover, exercise may be
beneficial on tumor outcome, by reducing insulin resistance and insulin/IGF-1
secretions.
Discussion.– Such intervention may appear challenging because of multiple
cancer-related symptoms (pain, fatigue, depression, denutrition) that can appear
as barriers to physical activity. On the contrary, we hypothesize that an adapted
physical exercise program may improve symptoms and QoL. If physical activity
intervention proves to be feasible, effective and cost-effective, implementing
standardized physical exercise programs in addition to chemotherapy in
advanced PAC will be a logical next step. This project will be labellized by the
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